These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 37804267)
1. Fatty Liver Change in Older Adults as an Important Risk Factor for Type 2 Diabetes: A Nationwide Cohort Study. Park KY; Park JH; Han K; Yu SH; Lee CB; Kim DS; Park HK; Hwang HS; Hong S Mayo Clin Proc; 2023 Dec; 98(12):1809-1819. PubMed ID: 37804267 [TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study. Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672 [TBL] [Abstract][Full Text] [Related]
3. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471 [TBL] [Abstract][Full Text] [Related]
4. Changes in Fatty Liver Disease and Incident Diabetes Mellitus in Young Korean Adults. Park KY; Hwang HS; Han K; Park HK Am J Prev Med; 2024 Apr; 66(4):717-724. PubMed ID: 38008134 [TBL] [Abstract][Full Text] [Related]
5. Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. Dutta D; Mondal SA; Kumar M; Hasanoor Reza AH; Biswas D; Singh P; Chakrabarti S; Mukhopadhyay S Diabet Med; 2014 Dec; 31(12):1594-9. PubMed ID: 24975463 [TBL] [Abstract][Full Text] [Related]
6. Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly. Liu M; Wang J; Zeng J; Cao X; He Y J Clin Endocrinol Metab; 2017 Apr; 102(4):1309-1316. PubMed ID: 28324002 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States. Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016 [TBL] [Abstract][Full Text] [Related]
8. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. Franch-Nadal J; Caballeria L; Mata-Cases M; Mauricio D; Giraldez-García C; Mancera J; Goday A; Mundet-Tudurí X; Regidor E; PLoS One; 2018; 13(6):e0198327. PubMed ID: 29856820 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease. Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB; JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956 [TBL] [Abstract][Full Text] [Related]
14. The bidirectional relationship between NAFLD and type 2 diabetes: A prospective population-based cohort study. Wang M; Zhao Y; He Y; Zhang L; Liu J; Zheng S; Bai Y Nutr Metab Cardiovasc Dis; 2023 Aug; 33(8):1521-1528. PubMed ID: 37336719 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016. Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544 [TBL] [Abstract][Full Text] [Related]
16. Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus. Xu J; Wu L; Deng J; Yang L; Wang Y; Tian H; Ji Y; Xia Q; Han Z; Cheng Y; Lu X BMC Endocr Disord; 2023 Sep; 23(1):201. PubMed ID: 37726718 [TBL] [Abstract][Full Text] [Related]
17. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population. Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716 [TBL] [Abstract][Full Text] [Related]
18. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Ligthart S; van Herpt TT; Leening MJ; Kavousi M; Hofman A; Stricker BH; van Hoek M; Sijbrands EJ; Franco OH; Dehghan A Lancet Diabetes Endocrinol; 2016 Jan; 4(1):44-51. PubMed ID: 26575606 [TBL] [Abstract][Full Text] [Related]
19. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. Neeland IJ; Turer AT; Ayers CR; Powell-Wiley TM; Vega GL; Farzaneh-Far R; Grundy SM; Khera A; McGuire DK; de Lemos JA JAMA; 2012 Sep; 308(11):1150-9. PubMed ID: 22990274 [TBL] [Abstract][Full Text] [Related]
20. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals. Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]